glp 1 for autoimmune disorders Association between diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study Can Microdose GLP-1 Agonists Help

There has also been recent research highlighting the safe and effective use of these therapies in type 1 diabetes, especially in combination with automated insulin delivery (AID)

Hans Lee, medical director for the Wellstar congestive heart failure program

doi:10.1002/jcsm.12922

Strong legal advocacy to challenge denials and protect access to critical treatments

After a recent tirzepatide dose escalation, the patient developed severe vomiting, metabolic derangements, sepsis physiology, and later GI bleeding, requiring coordinated management by endocrinology, gastroenterology, and cardiology.As GLP-1 use expands, careful dose titration, awareness of overlapping syndromes, and early multidisciplinary involvement are essential

Nakatani Y, Kawabe A, Matsumura M, Aso Y, Yasu T, Banba N, Nakamoto T